University Multiprofessional Hospital For Active Treatment Kanev AD

At the University Multiprofessional Hospital For Active Treatment Kanev AD in Ruse, research in cardiovascular diseases focuses on reducing major heart and vascular events and improving treatment options for people with established cardiovascular disease and related risk factors.

• Studies of therapies aimed at lowering lipoprotein(a) to reduce serious cardiovascular complications
• Evaluation of clot-dissolving treatment for proximal deep vein thrombosis
• Work on preventing future events in patients with established atherosclerotic cardiovascular disease

These trials are designed to test new approaches that may improve prevention, safety, and overall outcomes in high-risk heart and vascular care.

This site also supports clinical research in bacterial infections, with a strong focus on difficult-to-treat infections that affect the urinary tract, abdomen, lungs, bloodstream, and skin.

• Testing new antibiotic options for complicated urinary tract infection and acute pyelonephritis
• Studies in serious hospital infections such as hospital-acquired pneumonia, ventilator-associated pneumonia, and sepsis
• Research on treatments for acute bacterial skin and skin structure infections and other gram-negative infections

The goal is to improve infection control, expand treatment choices, and strengthen care for patients with severe or resistant bacterial disease.

Clinical trials in digestive system diseases at this hospital include studies for inflammatory bowel conditions, especially ulcerative colitis.

• Assessment of treatments for moderately to severely active ulcerative colitis
• Research aimed at improving long-term disease control and symptom relief
• Evaluation of new therapies intended to support better quality of life in chronic intestinal inflammation

These studies are focused on finding safer and more effective ways to manage persistent gastrointestinal inflammation.

The oncology research portfolio includes trials for nonmuscle invasive bladder cancer, with attention on treatments that may help control localized tumors and reduce the need for more invasive care.

• Testing a novel therapy for low-grade nonmuscle invasive bladder cancer
• Evaluating tumor-ablative activity and treatment effectiveness
• Exploring options that may improve disease management while preserving bladder function

Research in this area aims to expand treatment possibilities for patients with early-stage bladder cancer.

In nervous system diseases, the site is involved in studies of Alzheimer’s disease psychosis, particularly symptoms such as hallucinations and delusions.

• Trials evaluating treatments for psychosis associated with Alzheimer’s disease
• Research focused on reducing hallucinations and delusions
• Assessment of long-term safety, tolerability, and symptom control in affected patients

These studies seek better ways to manage complex neuropsychiatric symptoms and support patients and caregivers.

Work in nutritional and metabolic diseases at this site includes research on severe hypertriglyceridemia, a condition linked to elevated blood fats and increased health risks.

• Evaluation of therapies designed to lower very high triglyceride levels
• Studies focused on safety and tolerability in people with severe hypertriglyceridemia
• Research aimed at improving long-term metabolic risk management

The objective is to identify new treatment approaches that may help reduce complications related to abnormal lipid levels.

Clinical research in skin and connective tissue diseases includes studies for acute bacterial skin and skin structure infections, with special attention to pediatric care.

• Testing treatment options for children with acute bacterial skin and skin structure infections
• Assessing safety, tolerability, and practical use of new infection therapies
• Supporting better management of skin infections that may require urgent treatment

These trials aim to improve outcomes for younger patients facing serious skin-related bacterial infections.

The site also contributes to research in mental disorders, especially symptoms connected to Alzheimer’s disease psychosis.

• Studies of treatments for hallucinations and delusions in Alzheimer’s-related psychosis
• Evaluation of symptom reduction and day-to-day functioning
• Research exploring better care options for challenging psychiatric symptoms in dementia

These trials are intended to improve treatment effectiveness and support more compassionate care for patients with complex neuropsychiatric symptoms.